GlassScriptPhysician profile
Rachel Black
NPI 1003276528
$4,849.64
in general payments reported to CMS, 2019-2025
39 companies · $1,506 in 2025
The $1,506 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $69.93 · 2021: $184 · 2022: $179 · 2023: $1,401 · 2024: $1,186 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,993 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,993.18 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $646.12 | 2019-2025 | Fasenra, Breztri, Symbicort |
| Genzyme Corporation | $465.55 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.18 | 2023-2025 | Ofev, Jascayd |
| Grifols USA, LLC | $305.93 | 2021-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $273.12 | 2019-2025 | Tyvaso, Orenitram, Remodulin |
| Regeneron Healthcare Solutions, INC. | $261.05 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $255.40 | 2019-2025 | Trelegy Ellipta, Nucala |
| Intuitive Surgical, INC. | $228.45 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $204.38 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $202.91 | 2023-2025 | Opsumit, Uptravi |
| Philips North America LLC | $202.51 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Insmed, INC. | $157.82 | 2019-2025 | Arikayce |
| Inari Medical, INC. | $132.15 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $102.84 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $99.98 | 2025 | Smartvest |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Inspire Medical Systems, INC. | $83.81 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $79.96 | 2024-2025 | Winrevair, Zerbaxa |
| Amgen INC. | $78.61 | 2023-2025 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $64.93 | 2025 | Lumryz |
| Alexion Pharmaceuticals, INC. | $57.99 | 2023 | Ultomiris |
| Jazz Pharmaceuticals INC. | $53.69 | 2023-2025 | |
| Astellas Pharma US INC | $49.58 | 2023-2025 | Cresemba |
| Axsome Therapeutics, INC. | $43.87 | 2024-2025 | Sunosi |
| Lilly USA, LLC | $39.43 | 2025 | Zepbound |
| Gilead Sciences, INC. | $36.72 | 2023 | |
| La Jolla Pharmaceutical Company | $33.79 | 2021-2024 | Giapreza |
| Zoll Respicardia, INC. | $30.59 | 2023 | Remede System |
| Mallinckrodt Hospital Products INC. | $29.64 | 2023 | Acthar |
| Pharming Healthcare, INC. | $27.23 | 2023 | Ruconest |
| Takeda Pharmaceuticals U.S.A., INC. | $26.62 | 2025 | Glassia |
| Itamar Medical INC | $26.13 | 2025 | Watchpatone |
| Verona Pharma, INC. | $25.02 | 2025 | Ohtuvayre |
| Pfizer INC. | $20.72 | 2024 | |
| Vifor Pharma, INC. | $18.97 | 2024 | Veltassa |
| Janssen Pharmaceuticals, INC | $17.65 | 2024 | Xarelto |
| Boston Scientific Corporation | $16.47 | 2025 | Watchman Flx |
| Mylan Specialty L.P. | $15.83 | 2024 | Yupelri |
| Angiodynamics, INC. | $14.05 | 2025 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.